Drug Type Small molecule drug |
Synonyms Imitrodast sodium (JAN), Logran, CS 518 + [3] |
Target |
Action inhibitors |
Mechanism TXA2 synthase inhibitors(Thromboxane A2 synthase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC13H12N2NaO2S |
InChIKeyPLWYYRJTTTZSBZ-UHFFFAOYSA-N |
CAS Registry113817-57-5 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D09774 | - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | NDA/BLA | Japan | - | |
| Arterial thrombosis | Phase 2 | Japan | - | |
| Coronary Vasospasm | Phase 2 | Japan | - |





